GB Patent

GB1517278A — Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates

Assigned to Glaxo Laboratories Ltd · Expires 1978-07-12 · 48y expired

What this patent protects

Patent listed against azelastine-hydrochloride.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: GB1517278A
Jurisdiction: GB
Classification: —
Expires: 1978-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.